Les complications liées à la fibronectine sont-elles réversibles ?
Certaines complications peuvent être réversibles avec un traitement approprié.
FibronectinesComplicationsTraitement
#3
Comment la fibronectine est-elle liée aux maladies auto-immunes ?
Des niveaux anormaux de fibronectine peuvent exacerber les maladies auto-immunes.
FibronectinesMaladies auto-immunesExacerbation
#4
Les complications de fibronectine affectent-elles la qualité de vie ?
Oui, elles peuvent réduire la qualité de vie en affectant la mobilité et la santé générale.
FibronectinesQualité de vieSanté générale
#5
Y a-t-il des risques de cancer liés à la fibronectine ?
Des études montrent un lien entre des niveaux élevés de fibronectine et certains cancers.
FibronectinesCancerRisques
Facteurs de risque
5
#1
Quels facteurs de risque influencent les niveaux de fibronectine ?
L'obésité, le tabagisme et les maladies chroniques peuvent influencer les niveaux.
FibronectinesObésitéTabagisme
#2
L'âge est-il un facteur de risque pour la fibronectine ?
Oui, le vieillissement peut affecter la production et la fonction de la fibronectine.
FibronectinesVieillissementProduction
#3
Les maladies métaboliques impactent-elles la fibronectine ?
Oui, des maladies comme le diabète peuvent altérer les niveaux de fibronectine.
FibronectinesDiabèteMaladies métaboliques
#4
Le stress chronique affecte-t-il la fibronectine ?
Oui, le stress chronique peut perturber la régulation de la fibronectine dans l'organisme.
FibronectinesStress chroniqueRégulation
#5
Y a-t-il un lien entre l'alimentation et la fibronectine ?
Oui, une alimentation riche en antioxydants peut aider à réguler les niveaux de fibronectine.
FibronectinesAlimentationAntioxydants
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fibronectines : Questions médicales les plus fréquentes",
"headline": "Fibronectines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fibronectines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-16",
"dateModified": "2026-08-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fibronectines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de la matrice extracellulaire",
"url": "https://questionsmedicales.fr/mesh/D016326",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de la matrice extracellulaire",
"code": {
"@type": "MedicalCode",
"code": "D016326",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.860.300"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fibronectines",
"alternateName": "Fibronectins",
"code": {
"@type": "MedicalCode",
"code": "D005353",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Neha E H Dinesh",
"url": "https://questionsmedicales.fr/author/Neha%20E%20H%20Dinesh",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada."
}
},
{
"@type": "Person",
"name": "Philippe M Campeau",
"url": "https://questionsmedicales.fr/author/Philippe%20M%20Campeau",
"affiliation": {
"@type": "Organization",
"name": "CHU Sainte-Justine Research Center, Montreal, Quebec, Canada."
}
},
{
"@type": "Person",
"name": "Dieter P Reinhardt",
"url": "https://questionsmedicales.fr/author/Dieter%20P%20Reinhardt",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada."
}
},
{
"@type": "Person",
"name": "Jean E Schwarzbauer",
"url": "https://questionsmedicales.fr/author/Jean%20E%20Schwarzbauer",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Biology, Princeton University, Princeton, NJ, 08544, USA. jschwarz@princeton.edu."
}
},
{
"@type": "Person",
"name": "Dorota Krzyżanowska-Gołąb",
"url": "https://questionsmedicales.fr/author/Dorota%20Krzy%C5%BCanowska-Go%C5%82%C4%85b",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry and Immunochemistry, Wroclaw Medical University, 50-369 Wrocław, Poland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Different roles of endothelial cell-derived fibronectin and plasma fibronectin in endothelial dysfunction.",
"datePublished": "2023-10-25",
"url": "https://questionsmedicales.fr/article/38813506",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.55730/1300-0144.5735"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mutations in fibronectin dysregulate chondrogenesis in skeletal dysplasia.",
"datePublished": "2024-10-05",
"url": "https://questionsmedicales.fr/article/39367925",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00018-024-05444-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Isolation of Chondrocytes and Chondroprogenitors using Fibronectin Adhesion and Migratory Assay.",
"datePublished": "2024-10-04",
"url": "https://questionsmedicales.fr/article/39431785",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3791/67160"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of serum fibronectin levels and fibronectin gene polymorphism in patients receiving intravesical BCG therapy for non-muscle invasive bladder cancer and its prognostic value.",
"datePublished": "2024-09-28",
"url": "https://questionsmedicales.fr/article/39342212",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12894-024-01592-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "In Silico Insights Reveal Fibronectin 1 as a Theranostic Marker in Gastric Cancer.",
"datePublished": "2024-10-16",
"url": "https://questionsmedicales.fr/article/39456895",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms252011113"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Scléroprotéines",
"item": "https://questionsmedicales.fr/mesh/D012596"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines de la matrice extracellulaire",
"item": "https://questionsmedicales.fr/mesh/D016326"
},
{
"@type": "ListItem",
"position": 6,
"name": "Fibronectines",
"item": "https://questionsmedicales.fr/mesh/D005353"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fibronectines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fibronectines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fibronectines",
"description": "Comment diagnostiquer une anomalie de fibronectine ?\nQuels tests sont utilisés pour mesurer la fibronectine ?\nLes niveaux de fibronectine sont-ils liés à des maladies ?\nPeut-on détecter la fibronectine dans le liquide amniotique ?\nQuel rôle joue la fibronectine dans le diagnostic des maladies ?",
"url": "https://questionsmedicales.fr/mesh/D005353#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fibronectines",
"description": "Quels symptômes sont associés à une carence en fibronectine ?\nLa fibronectine affecte-t-elle la douleur ?\nQuels signes cliniques indiquent un excès de fibronectine ?\nLa fibronectine influence-t-elle la cicatrisation des plaies ?\nPeut-on observer des symptômes cutanés liés à la fibronectine ?",
"url": "https://questionsmedicales.fr/mesh/D005353#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fibronectines",
"description": "Comment prévenir les troubles liés à la fibronectine ?\nY a-t-il des mesures préventives spécifiques ?\nLa gestion du stress aide-t-elle la fibronectine ?\nLes examens réguliers peuvent-ils prévenir des problèmes de fibronectine ?\nL'éducation sur la santé influence-t-elle la fibronectine ?",
"url": "https://questionsmedicales.fr/mesh/D005353#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fibronectines",
"description": "Quels traitements ciblent les anomalies de fibronectine ?\nLa supplémentation en fibronectine est-elle possible ?\nComment la fibronectine est-elle utilisée en médecine régénérative ?\nLes traitements pour fibrose impliquent-ils la fibronectine ?\nY a-t-il des thérapies expérimentales pour la fibronectine ?",
"url": "https://questionsmedicales.fr/mesh/D005353#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fibronectines",
"description": "Quelles complications peuvent survenir avec des niveaux anormaux de fibronectine ?\nLes complications liées à la fibronectine sont-elles réversibles ?\nComment la fibronectine est-elle liée aux maladies auto-immunes ?\nLes complications de fibronectine affectent-elles la qualité de vie ?\nY a-t-il des risques de cancer liés à la fibronectine ?",
"url": "https://questionsmedicales.fr/mesh/D005353#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fibronectines",
"description": "Quels facteurs de risque influencent les niveaux de fibronectine ?\nL'âge est-il un facteur de risque pour la fibronectine ?\nLes maladies métaboliques impactent-elles la fibronectine ?\nLe stress chronique affecte-t-il la fibronectine ?\nY a-t-il un lien entre l'alimentation et la fibronectine ?",
"url": "https://questionsmedicales.fr/mesh/D005353#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie de fibronectine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies peuvent évaluer les niveaux de fibronectine."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer la fibronectine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ELISA et les dosages immunologiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les niveaux de fibronectine sont-ils liés à des maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux peuvent indiquer des maladies comme le cancer ou des troubles inflammatoires."
}
},
{
"@type": "Question",
"name": "Peut-on détecter la fibronectine dans le liquide amniotique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fibronectine fœtale peut être mesurée dans le liquide amniotique pour évaluer le risque d'accouchement prématuré."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la fibronectine dans le diagnostic des maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est un biomarqueur potentiel pour diverses pathologies, y compris les maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une carence en fibronectine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence peut entraîner des problèmes de cicatrisation et des troubles de l'adhésion cellulaire."
}
},
{
"@type": "Question",
"name": "La fibronectine affecte-t-elle la douleur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux peuvent être liés à des douleurs chroniques dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un excès de fibronectine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès peut être associé à des inflammations et des fibroses dans les tissus."
}
},
{
"@type": "Question",
"name": "La fibronectine influence-t-elle la cicatrisation des plaies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle joue un rôle crucial dans la régénération et la réparation des tissus."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes cutanés liés à la fibronectine ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans la fibronectine peuvent provoquer des problèmes cutanés, comme des ulcères."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés à la fibronectine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives spécifiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les facteurs de risque comme le tabagisme et l'obésité peut réduire les troubles."
}
},
{
"@type": "Question",
"name": "La gestion du stress aide-t-elle la fibronectine ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut améliorer la santé cellulaire et la régénération des tissus."
}
},
{
"@type": "Question",
"name": "Les examens réguliers peuvent-ils prévenir des problèmes de fibronectine ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies."
}
},
{
"@type": "Question",
"name": "L'éducation sur la santé influence-t-elle la fibronectine ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une meilleure éducation sur la santé peut encourager des choix de vie favorables."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les anomalies de fibronectine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des médicaments anti-inflammatoires peuvent être envisagés."
}
},
{
"@type": "Question",
"name": "La supplémentation en fibronectine est-elle possible ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de supplémentation standardisée en fibronectine."
}
},
{
"@type": "Question",
"name": "Comment la fibronectine est-elle utilisée en médecine régénérative ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est utilisée pour favoriser l'adhésion cellulaire dans les greffes et les implants."
}
},
{
"@type": "Question",
"name": "Les traitements pour fibrose impliquent-ils la fibronectine ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements ciblant la fibronectine peuvent aider à réduire la fibrose."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies expérimentales pour la fibronectine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur des thérapies ciblant la fibronectine dans diverses pathologies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des niveaux anormaux de fibronectine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles de la cicatrisation et des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les complications liées à la fibronectine sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment la fibronectine est-elle liée aux maladies auto-immunes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de fibronectine peuvent exacerber les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les complications de fibronectine affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent réduire la qualité de vie en affectant la mobilité et la santé générale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer liés à la fibronectine ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent un lien entre des niveaux élevés de fibronectine et certains cancers."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent les niveaux de fibronectine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme et les maladies chroniques peuvent influencer les niveaux."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour la fibronectine ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la production et la fonction de la fibronectine."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques impactent-elles la fibronectine ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète peuvent altérer les niveaux de fibronectine."
}
},
{
"@type": "Question",
"name": "Le stress chronique affecte-t-il la fibronectine ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la régulation de la fibronectine dans l'organisme."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre l'alimentation et la fibronectine ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut aider à réguler les niveaux de fibronectine."
}
}
]
}
]
}
Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng-Li Road, Tainan 70101, Taiwan.
Department of Obstetrics and Gynecology, Tainan Hospital, Ministry of Health and Welfare, Tainan 700007, Taiwan.
Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng-Li Road, Tainan 70101, Taiwan.
Atherosclerosis is significantly influenced by endothelial cell activation and dysfunction. Studies have demonstrated the substantial presence of fibronectin (Fn) within atherosclerotic plaques, promo...
Initially, endothelial cell injury was induced by exposing the cells to oxidized low-density lipoprotein (ox-LDL) and subsequently we generated a mutant strain of aortic endothelial cells with Fn knoc...
The results showed that the Fn...
Aortic Fn...
Fibronectin (FN) is an extracellular matrix glycoprotein essential for the development and function of major vertebrate organ systems. Mutations in FN result in an autosomal dominant skeletal dysplasi...
Chondroprogenitor cells (CPCs), recently identified as a distinct subpopulation, exhibit promise due to their mesenchymal properties, heightened chondrogenesis, and limited hypertrophic traits. The en...
Bladder cancer continues to be a significant health issue, leading to ongoing research into novel biomarkers and treatment strategies. This study aims to evaluate the potential of serum fibronectin le...
Between June 2022 and December 2022, data of 73 patients who applied to the Mersin University Urology Clinic due to NMIBC and were followed and treated in our clinic, receiving intravesical BCG treatm...
The mean serum fibronectin level in the patient group was 76.794 ± 66.998ng/ml. Simultaneously, it was 50.486 ± 25.156ng/ml in the control group, and these differences in serum fibronectin levels were...
The statistically higher concentrations of serum fibronectin levels in patients with bladder cancer observed in our study are a noteworthy finding. These findings suggest that serum fibronectin levels...
Gastric cancer (GC) is a complex and highly variable disease, ranking among the top five cancers diagnosed globally, and a leading cause of cancer-related deaths. Emerging from stomach lining cells am...
Glioblastoma (GBM) is the most lethal and common malignant primary brain tumor in adults. An important feature that supports GBM aggressiveness is the unique composition of its extracellular matrix (E...
Preeclampsia is a life-threatening complication of pregnancy that occurs in approximately 7% of all pregnancies. In India, the incidence of preeclampsia is 8%-10% and the prevalence is 5.4%, whereas t...
This study was aimed at evaluating the diagnostic accuracy of serum glycosylated fibronectin (S. GlyFn) in the prediction of preeclampsia....
A nested case-control study was carried out for 16 months in the department of obstetrics and gynecology. A total of 240 women were recruited and followed after written consent and ethical clearance. ...
The mean S. GlyFn level was significantly higher at the time of enrollment among those women who later developed preeclampsia (127.59 ± 27.68 ng/m) as compared to controls (107.79-53.51 ng/mL). GlyFn ...
S. GlyFn, at a cutoff value of 126.70 ng/mL, had good sensitivity to discriminate PE from normotensive and was also a good prognostic marker....
Pectin interacts with fibronectin (FN), a modular protein in the extracellular matrix. This interaction is significant as FN plays a pivotal role by binding to the receptor integrin α5β1. However, the...
Group B Streptococcus (GBS) is a commensal of healthy adults and an important pathogen in newborns, the elderly and immunocompromised individuals. GBS displays several virulence factors that promote c...
In this study, fibronectin was identified as a novel ligand for the Srr2 adhesin of GBS. A derivative of the ST-17 strain BM110 overexpressing the srr2 gene showed an increased ability to bind fibrino...
By combining genetic and biochemical approaches, we demonstrate a new role for Srr2, namely interacting with fibronectin. We characterised the molecular mechanism of this interaction and demonstrated ...
Fibronectin glomerulopathy (FNG) is a rare autosomal dominant glomerulopathy that can lead to nephrotic syndrome. Here we report the case of an elderly patient diagnosed with FNG, exhibiting nephrotic...
A 75-year-old Korean female visited the nephrology clinic after experiencing generalized edema for 2 months. Her serum creatinine was 1.36 mg/dL, and urine protein-to-creatinine ratio was 3.99 g/g. Ki...
We report the case of a 75-year-old patient with nephrotic-range proteinuria, who was diagnosed with FNG, and found to harbor a FN1 gene mutation. In this case, conservative treatment including ARB yi...